510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K241741Substantially Equivalent

SAFElife™ Fentanyl Urine Home Test (Cassette); SAFElife™ Fentanyl (FTY) Urine Test Cassette; SAFElife™ T-Dip Fentanyl Urine Home Test (Dip Card); SAFElife™ T-Dip Fentanyl (FTY) Urine Test Panel

Guangzhou Wondfo Biotech Co., Ltd., Guangzhou, CN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K241741 is the FDA 510(k) clearance record for SAFElife™ Fentanyl Urine Home Test (Cassette); SAFElife™ Fentanyl (FTY) Urine Test Cassette; SAFElife™ T-Dip Fentanyl Urine Home Test (Dip Card); SAFElife™ T-Dip Fentanyl (FTY) Urine Test Panel, a class II device, cleared for Guangzhou Wondfo Biotech Co., Ltd. on under FDA product code NGL (Test, Opiates, Over The Counter). FDA records list 43 510(k) clearances for Guangzhou Wondfo Biotech Co., Ltd., from to . As of , FDA records show no recalls naming K241741.

Clearance record

Decision date
Received
(29 days to decision)
Product code
NGL Test, Opiates, Over The Counter
Regulation
21 CFR 862.3650
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Guangzhou Wondfo Biotech Co., Ltd. #8 Lizhishan Rd., Science City, Huangpu District, Guangzhou, CN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NGL

Trailing 12 months
1 clearance under product code NGL in the twelve months to October 2026, December 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code NGL, trailing twelve months
MonthClearances
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260